CDC guidance expected for high-risk sexual exposure. Centers for Disease Control and Infection. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply. NLM AIDSLINE Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


CDC guidance expected for high-risk sexual exposure. Centers for Disease Control and Infection. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

AIDS Alert. 1997 Jul;12(7):75-7. Unique Identifier : AIDSLINE MED/97702684


Abstract: The Centers for Disease Control and Prevention (CDC) is expected to issue recommendations for prophylactic treatment for health care workers exposed to HIV on the job. The post-exposure protocol will include a three-drug regimen for severe exposures, and it is likely that newer drugs, such as nelfinavir, will be included in the guidelines. These aggressive treatments may lead to similar guidelines for other high-risk exposures, such as people exposed through rape or through unprotected sex with infected partners. Monotherapy is never an acceptable prophylactic treatment.
Keywords: *HIV Infections/DRUG THERAPY *HIV Infections/TRANSMISSION *Occupational Exposure/ADVERSE EFFECTSKWDhivinfections/drugtherapyKWDhivinfections/transmissionKWDoccupationalexposure/adverseeffects
971030
M97A1299

Copyright © 1997 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .